Login to Your Account

Pharma: Other News To Note

Monday, January 28, 2013
• Otsuka Pharmaceutical Co. Ltd., of Tokyo, and the FDA notified health care professionals of significant liver injury associated with the use of Samsca (tolvaptan).

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription